Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call

Rhea-AI Summary

Personalis has rescheduled its ASCO data highlights conference call to Friday, June 21, 2024, at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time. The call was initially set for Wednesday, June 19, 2024. Participants can join the call by dialing specific numbers for domestic or international access. Additionally, the call will be webcast online through the company's investor relations website, with a replay available after the event.

Positive

• Rescheduled ASCO conference call emphasizes the importance of ASCO data highlights for Personalis.
• Availability of the call replay ensures accessibility for all interested stakeholders, regardless of time zone.

Negative

• Rescheduling the conference call may inconvenience some participants who had planned for the original date.
• The change in schedule might raise concerns about the company's preparedness or unforeseen issues.

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it has updated the ASCO data highlights conference call to Friday, June 21, 2024 at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time. Personalis had previously announced it would host the conference call on Wednesday, June 19, 2024 at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time.

Webcast and Conference Call Information

Interested parties may access the call by dialing 877-407-9042 for domestic callers or 201-689-8569 for international callers. The webinar of the call may be accessed by visiting the Events section of the company's website at investors.personalis.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company's website.

About Personalis, Inc.

At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest time points, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240613405471/en/

Investors:

Caroline Corner

investors@personalis.com

415-202-5678

Media:

pr@personalis.com

Source: Personalis, Inc.

FAQ

When is the rescheduled Personalis ASCO highlights conference call?

The rescheduled ASCO highlights conference call will be held on Friday, June 21, 2024, at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time.

How can I join the Personalis ASCO highlights conference call?

You can join the call by dialing 877-407-9042 for domestic callers or 201-689-8569 for international callers.

Where can I access the webcast for the Personalis ASCO highlights conference call?

The webcast can be accessed by visiting the Events section of the Personalis investor relations website.

Will there be a replay available for the Personalis ASCO highlights conference call?

Yes, a replay will be available shortly after the conclusion of the call and will be archived on the company's website.